Advertisment Policy

The Journal of Pharmaceutical, Biomedical, and Chemistry Research (JPBCR) prohibits advertising on its main website, https://jpbcr.in/index.php/JPBCR/index. But we allow advertising on other official JPBCR social media platforms. JPBCR neither supports the promoted firm or product nor permits advertising to influence editorial choices or content.

Advertising Acceptance

JPBCR maintains the authority to reject any advertisement that is incongruent with our goals. JPBCR shall comply with all ethical and widely acknowledged advertising standards, ensuring that its operations align with its vision and goal. The subsequent categories of ads are not allowed

  • Political and religious advertisements
  • Advertisements that claim to offer a miracle cure or method
  • Advertisements for alcohol, tobacco or any related product(s)
  • Advertisements for weapons, firearms, ammunition and fireworks
  • Advertisements for pornography and related materials and services
  • Advertisements that make unsubstantiated health claims for the products advertised

Advertising Policy

  • Advertisements will always be allowed only after approval of JPBCR /
  • Advertisements, icons, and logos must be distinguishable from editorial content.
  • Advertisers may be required to submit supporting documentation to substantiate claims.
  • Advertisements may not imply endorsement by the JPBCR
  • Neither advertisers nor their agents may collect personal information from any user viewing the JPBCR website except with the user's knowledge and permission and only after giving the user substantive information about the uses to which the information will be put.

Advertising revenue is used to support Authors with limited funds to pay Article Processing Charges (APC).

For questions about online advertising on the JPBCR, contact the sales team at +919975808130 or jpbcreditor@gmail.com

Disclaimer

The author(s) of each article in this Journal bear exclusive responsibility for its content; publication does not imply any endorsement by the Editors, Reviewers, Management, or JPBCR regarding the accuracy or sufficiency of the data to support the conclusions drawn, nor the adequacy of the experimental design or methodology employed.

Nevertheless, considering the potential for human error by the authors, editors, or publisher, none of those involved in the preparation of this work guarantees that the information contained herein is entirely accurate or complete, and they bear no responsibility for any errors, omissions, or outcomes resulting from the use of such information. Readers are encouraged to verify the information presented above with additional sources.

The views articulated in JPBCR represent those of the writers and contributors and do not necessarily align with the perspectives of Creative Pharma Assent, the editors, the editorial board, JPBCR, or the institutions with which the authors are associated.

COPE Guidelines

Everyone is advised to follow these COPE Guidelines for reference and strict compliance

COPE GUIDELINES